Analyst Research

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Jazz Pharmaceuticals PLC To Meet Or Exceed Prior FY 2012 Revenue Guidance-Conference Call


Tuesday, 8 Jan 2013 06:00pm EST 

Jazz Pharmaceuticals PLC announced that for fiscal 2012, it expects total revenues to meet or exceed its prior guidance of $575 million to $585 million. 

Latest Key Developments in Pharmaceuticals

Company Quote

150.8
-1.69 -1.11%
11 Jul 2014